Can probiotic, prebiotic, and synbiotic supplementation modulate the gut-liver axis in type 2 diabetes? A narrative and systematic review of clinical trials

BACKGROUND: Type 2 diabetes, one of the most common noncommunicable diseases, is a metabolic disorder that results in failed homeostatic control in several body systems, including hepatic function. Due to the gut microbiome’s potential role in diabetes’ pathogenesis, prebiotics, probiotics, and synb...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Najjar, Yousef, Arabi, Maryam, Paul, Pradipta, Chaari, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751375/
https://www.ncbi.nlm.nih.gov/pubmed/36532552
http://dx.doi.org/10.3389/fnut.2022.1052619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751375/
https://www.ncbi.nlm.nih.gov/pubmed/36532552
http://dx.doi.org/10.3389/fnut.2022.1052619

Ejemplares similares